During the past decade, Clinicas Oncologicas Integradas - COI conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 15 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinicas Oncologicas Integradas - COI" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Amgen" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinicas Oncologicas Integradas - COI" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator and "Actoverco" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Clinicas Oncologicas Integradas - COI" are "Breast Cancer" (4 trials), "Gastric Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Prostatic Neoplasms" (2 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Clinicas Oncologicas Integradas - COI" in a lesser frequency.

Most popular intervention types in "Clinicas Oncologicas Integradas - COI" are "Drug" (26 trials), "Other" (5 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Abemaciclib" (3 trials), "Atezolizumab" (3 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinicas Oncologicas Integradas - COI" are 26 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinicas Oncologicas Integradas - COI". undefined are not yet recruiting, 2 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clinicas Oncologicas Integradas - COI, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinicas Oncologicas Integradas - COI, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".